100% Quality Guarantee
PhD-Level Technical Support
Key Features

Human BLyS/TNFSF13B/BAFF Recombinant Protein (RPES2597)

SKU RPES2597
Product Type Recombinant Protein
Species Human
Application Area Cytokines & Chemokines
€357 - €936

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human BLyS/TNFSF13B/BAFF Recombinant Protein

B lymphocyte stimulator (BLyS); also known as TNFSF13B; CD257 and BAFF; is single-pass type II membrane protein; which belongs to the tumour necrosis factor family. BAFF is abundantly expressed in peripheral blood Leukocytes and is especially present in monocytes and macrophages. BAFF is a cytokine that binds to receptors TNFRSF13B (TACI), TNFRSF17 (BCMA), and TNFRSEF13C (BAFFR). B-cell development, homeostasis, and selection are all influenced by these receptors. BLyS levels affect survival signals and selective apoptosis of autoantibody-producing B cells. BAFF is a powerful B-cell activator that has been shown to play an essential part in the multiplication and differentiation of B cells. Overexpression of BLyS in mice induces clinical and serological features of systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS). In human rheumatic diseases, BLyS is a potential drug target. The capacity of BLyS to control both size and repertoire in the peripheral B cell compartment raises the prospect that BLyS and its adversers might serve as a therapeutic trichotomy. As an agonist, BLS protein may improve humoral immunity in individuals with congenital or acquired immunodeficiency as a result of viral infection or cancer therapy. Human BLyS/TNFSF13B/BAFF Recombinant Protein is a highly pure recombinant protein developed by Assay Genie for use in a range of applications.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose